Advocacy Actions
Attend and Speak at the International Dental Industry Summit
During Sino-Dental (China International Dental Exhibition&Scientific Conference), EUCCC is invited to attend and speak at the International Dental Industry Summit
Read moreComments on the Tibet HFPC's 'Concept for Centralised Purchasing of Consumable Medical Devices and IVD'
The Healthcare Equipment (HCE) Working Group submitted comments on the Tibet Health and Family Planning Commission's (HFPC) draft 'Concept for Centralised Purchasing of Consumable Medical Devices and IVD'
Read moreChamber Discusses Corporate Volunteerism with Beijing Committee of the Communist Party of China
European Chamber hosted a CSR forum meeting on Corporate Volunteerism Development in China on June 7th at the Amway Experience Center in Beijing
Read moreChamber Discusses CSR Standards with MIIT
European chamber supported the organization of the 18th Sino-European CSR Roundtable Forum, which took place at Beijing International Hotel on June 5th 2018
Read moreMeeting with China National Drug Administration
Representatives from EUCCC Cosmetics Working Group had a meeting with officials from CNDA, Hainan FDA, and representatives from China Deputy Free Group and Hainan Duty Free Co. Ltd, to discuss the Shanghai Pudong Imported Nonspecial Cosmetics Notification Pilot policy, its implementation and impact to Hainan island duty-free shops.The Pudong notification is not valid when importing products by Hainan island duty-free shops, which prevents companies participating in the pilot from taking full advantage of the benefits.
The industry suggested the notification certificate be recognized and applied to customs declarations in all ports, including Hainan. Though CNDA did not accept the industry’s suggestion at the meeting, they promised to consider it and provide a solution to the industry afterwards. All sides thought that it was a very good discussion.
Comments on Implementation Measures for Drug Testing Data Protection (Interim)
European Chamber submitted comments to National Medical Products Administration (NMPA) on Implementation Measures for Drug Testing Data Protection (Interim)
Read moreComments to the CMDE's draft 'Basic Principle for the Conditional Approval of Urgently Required Medical Devices'
The Healthcare Equipment (HCE) Working Group submitted comments to the Centre of Medical Device Evaluation's (CMDE') draft 'Basic Principle for the Conditional Approval of Urgently Required Medical Devices'
Read moreComments to the Jiangsu Princing Bureau's "Updated Pricing Catalogue for Medical Services"
The Healthcare Equipment (HCE) Working Group submitted comments to the draft "Update of the Pricing Catalogue for Medical Services", published by the Pricing Bureau of Jiangsu Province
Read moreEuropean Chamber Speaks at World Manufacturing Convention 2018
European Chamber Speaks at World Manufacturing Convention 2018
Read moreComments on Draft of Medical Software QMS audit guidance to CMDE
COCIR members' comments on the draft guidance for medical software quality management system audit were submitted to Center for Medical Device Evaluation (CMDE)
Read more